盐酸氯化苯喹胺

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 四氢异喹啉
• 中文名称: 盐酸氯化苯喹胺
• 中文别名: 3-甲酰-N,N-二乙基-1,3,4,6,7,11β-六氢-9,11-二甲至-2H-苯并[a]喹-2-基醋酸酯盐酸盐
• 英文名称: [3-(diethylcarbamoyl)-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizin-2-yl] acetate;hydron;chloride
• 化学式: C22H33ClN2O5
• 分子量: 441.0
• InChiKey: KZLNXGBVFTWMPS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.84
• 重原子数：
  30
• 可旋转键数：
  7
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.64
• 拓扑面积：
  68.3
• 氢给体数：
  1
• 氢受体数：
  6

文献信息

• Anticoagulant contrast media
  申请人：Melton J. Laura

  公开号：US20050281746A1

  公开（公告）日：2005-12-22

  The present invention provides novel anticoagulant contrast agents, which comprise an organic scaffolding moiety, an organic anticoagulant moiety, and an imaging moiety. The invention also provides anticoagulant contrast media and methods of visualizing internal structures utilizing the novel anticoagulant contrast agents and anticoagulant contrast media.

  本发明提供了一种新型抗凝对比剂，包括有机支架基团、有机抗凝基团和成像基团。该发明还提供了抗凝对比介质和利用新型抗凝对比剂和抗凝对比介质来可视化内部结构的方法。
• Skin penetration system for salts of amine-functional drugs
  申请人：THE PROCTER & GAMBLE COMPANY

  公开号：EP0351897A2

  公开（公告）日：1990-01-24

  The invention involves pharmaceutical compositions for topical application comprising: (a) a pharmaceutically-acceptable salt of addition of an amine-functional drug (other than opioid analgesic drugs); (b) a C₇ to C₂₂ straight-chain or branched-chain, saturated or unsaturated, fatty acid having a melting point of less than about 50°C; and (c) a C₃-C₄ alkane diol.

  本发明涉及用于局部应用的药物组合物，包括 (a) 一种胺功能药物（阿片类镇痛药除外）的药学上可接受的加成盐； (b) C₇ 至 C₂₂ 直链或支链、饱和或不饱和脂肪酸，熔点低于约 50°C；以及 (c) C₃-C₄ 烷二醇。
• DRUGS
  申请人：Takeda Chemical Industries, Ltd.

  公开号：EP1145714A1

  公开（公告）日：2001-10-17

  The present invention relates to a medicine which comprises a compound (I) of the formula: [wherein the ring M is a heterocylic ring having -N=C<, -CO-N< or -CS-N< as a partial structure ―X=Y〈, Ra and Rb are bound to each other to form the ring A, or they are the same or different each representing a hydrogen atom or a substituent on the ring M; the rings A and B each is an optionally substituted homocycle or heterocycle, and at least one of them is an optionally substituted heterocycle; the ring C is an optionally substituted homocycle or heterocycle; the ring Z is an optionally substituted nitrogen-containing heterocycle; and n is an integer of 1 to 6] or a salt thereof in combination with a drug having an emetic action. The compounds (I) or their salts are useful as anti-emetic drugs. Particularly, vomiting caused by drugs having an emetic action can be inhibited by these compounds rapidly and safely at a low dose.

  本发明涉及一种药物，该药物由式(I)化合物组成： [其中环 M 是杂环，具有-N＝C〈、-CO-N〈或-CS-N〈作为部分结构-X＝Y〈、 Ra 和 Rb 相互结合形成环 A，或者它们相同或不同，各自代表环 M 上的一个氢原子或一个取代基； 环 A 和环 B 各自是任选取代的均环或杂环，其中至少一个是任选取代的杂环； 环 C 是任选取代的均环或杂环 环 Z 是任选取代的含氮杂环；以及 n 是 1 至 6 的整数］ 或其盐与具有催吐作用的药物结合使用。 化合物 (I) 或其盐类可用作止吐药。特别是，具有催吐作用的药物引起的呕吐，可以通过这些化合物以低剂量快速安全地抑制。
• Methods and systems of delivering medication via inhalation
  申请人：Next Safety, Inc.

  公开号：EP1911481A2

  公开（公告）日：2008-04-16

  Systems and methods for delivery of a drug to the respiratory system of a patient where the drug is supplied at a positive pressure relative to atmospheric pressure are provided. In particular, the drugs are delivered to the respiratory system of a patient who is capable of unassisted breathing. With the systems and methods of the present disclosure, medication available in a variety of forms is introduced in a controlled fashion into the air stream in aerosol, nebulized, or vaporized form.

  提供了向病人的呼吸系统输送药物的系统和方法，其中药物是在相对于大气压的正压下提供的。特别是，将药物输送到能够进行无助呼吸的患者的呼吸系统。利用本公开的系统和方法，可将各种形式的药物以气溶胶、雾化或汽化的形式有控制地引入气流中。
• Encapsulated screw locking system
  申请人：Stryker Trauma GmbH

  公开号：EP2335627A2

  公开（公告）日：2011-06-22

  The present invention discloses a system for securing at least one elongate fastener to an implant. At least one adhesive capsule is inserted in a recess preferably located along a longitudinal axis of the implant. The at least one adhesive capsule may be inserted in the recess and held in place therein by a holder. A plurality of adhesive capsules and holders may be inserted in one or more recesses located substantially along the longitudinal axis of the implant. The at least one adhesive capsule preferably has a casing housing an adhesive material configured to be pierced by the at least one fastener to secure the at least one fastener to an aperture of the implant. The casing of the adhesive capsule may form an annular passageway to receive a guide wire for aiding the insertion of the capsule in an implant having a longitudinal bore along at least a portion thereof.

  本发明公开了一种将至少一个细长紧固件固定在植入物上的系统。至少一个粘合胶囊被插入一个凹槽中，该凹槽最好位于种植体的纵轴上。至少一个粘合胶囊可插入凹槽中，并通过一个固定器固定在凹槽中。多个胶囊和支架可插入一个或多个凹槽中，凹槽大致沿种植体的纵向轴线分布。至少一个粘合剂胶囊最好有一个容纳粘合剂材料的外壳，该粘合剂材料可被至少一个紧固件穿透，以将至少一个紧固件固定在种植体的孔上。粘合胶囊的外壳可形成环形通道，用于接收导丝，以帮助将胶囊插入具有沿其至少部分纵向孔的种植体中。